Cost Effectiveness of TNF-𝛼 Inhibitors in Rheumatoid Arthritis

Table 5

Resulting ICERs in terms of improvement in the SF-6D.

Patient number	Cost differences between Treatment A and B	Difference in SF-6D between Treatment A and B	ICER per unit of improvement in the SF-6D	ICER per 10% improvement in the SF-6D
Patient 1	€6,451	0.35	€18,431	€1,843
Patient 2	€5,218	0.36	€14,494	€1,449
Patient 3	€5,444	0.22	€24,745	€2,475
Patient 4	€6,489	0.19	€34,152	€3,415
Patient 5	€5,302	0.18	€29,456	€2,946
Patient 6	€6,536	0.31	€21,084	€2,108
Patient 7	€6,476	0.18	€35,978	€3,598
Patient 8	€4,891	0.19	€25,742	€2,574
Patient 9	€5,705	0.19	€30,026	€3,003
Patient 10	€6,508	0.24	€27,117	€2,712
Patient 11	€5,649	0.37	€15,268	€1,527
Patient 12	€6,325	0.32	€19,766	€1,977
Patient 13	€1,802	0.37	€4,870	€487
Average	€5,600	0.27	€23,164	€2,316

The ICERs per unit improvement and per 10% improvement in the SF-6D following 6 months of TNF-α inhibitor therapy.